| TSC | technetium sulfur colloid; thiosemicarbazide; transverse spinal sclerosis; tuberous sclerosis |
|---|
| Tc-99m-HMPAO | Technetium 99m-hexamethylpropyleneamineoxime |
|---|---|
| 99mTc-HMPAO | Technetium-99-m-hexamethylpropyleneamine oxime |
| Tc-99m MDP | Technetium-99m Methylene Diphosphonate |
| Tc-MIBI | Technetium-99m methoxy isobutyl isonitrile |
| Tc-99m PYP | Technetium-99m pyrophosphate |
| technetium tc 99m pyrophosphate | <chemical> A radionuclide imaging agent used primarily in scintigraphy or tomography of the heart to evaluate the extent of the necrotic myocardial process. It has also been used in noninvasive tests for the distribution of organ involvement in different types of amyloidosis and for the evaluation of muscle necrosis in the extremities. Pharmacological action: radiopharmaceuticals, (12 Dec 1998) |
|---|---|
| technetium tc 99m sestamibi | <chemical> (oc-6-11)-hexakis(1-isocyano-2-methoxy-2-methylpropane)technetium(1+)-99mtc. A technetium imaging agent used to reveal blood-starved cardiac tissue during a heart attack. Pharmacological action: radiopharmaceuticals. Chemical name: Technetium(1+)-99Tc, hexakis(1-isocyano-2-methoxy-2-methylpropane)-, (OC-6-11)- (12 Dec 1998) |
| technetium tc 99m sulfur colloid | <chemical> A gamma-emitting radionuclide imaging agent used for the diagnosis of diseases in many tissues, particularly in the gastrointestinal system, liver, and spleen. Pharmacological action: radiopharmaceuticals. (12 Dec 1998) |